These practices align WHO member states in a better position to achieve targets by 2030: 80% of people with diabetes are diagnosed; 80% of people with diagnosed diabetes have good control of glycaemia; 100% of people with type 1 diabetes have access to affordable insulin and blood glucose self-monitoring. The gene discussed is INS; the disease is type 1 diabetes mellitus.